VETOQUINOL launches UPCARD©, an innovative drug for congestive heart failure in dogs
14/09/2015 | 19:45
- Public releases
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures